InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| THP1-Dual™ Cells | Induction of robust type I interferon levels by oncolytic reovirus requires b... | 2021 | Hum Gene Ther. | Oosenbrug T. et al. | DOI: 10.1089/hum.2021.140 |
| OVA protein | Synergistic enhancement of immunological responses triggered by hyperthermia ... | 2021 | Bioact Mater. | Yu J. et al. | DOI: 10.1016/j.bioactmat.2021.05.030 |
| Jurkat Reporter Cells (NFAT) | Soluble trivalent engagers redirect cytolytic T cell activity toward tumor en... | 2021 | Cell Rep Med. | Fierle J.K. et al. | DOI: 10.1016/j.xcrm.2021.100362 |
| QUANTI-Luc™: Luciferase Detection Reagent | Soluble trivalent engagers redirect cytolytic T cell activity toward tumor en... | 2021 | Cell Rep Med. | Fierle J.K. et al. | DOI: 10.1016/j.xcrm.2021.100362 |
| FLA-BS (Standard or Ultrapure) | Compromised mitochondrial quality control triggers lipin1-related rhabdomyoly... | 2021 | Cell Rep Med | Hamel Y. et al. | DOI: 10.1016/j.xcrm.2021.100370 |
| Pam3CSK4 | Compromised mitochondrial quality control triggers lipin1-related rhabdomyoly... | 2021 | Cell Rep Med | Hamel Y. et al. | DOI: 10.1016/j.xcrm.2021.100370 |
| ODN TTAGGG (A151) | Compromised mitochondrial quality control triggers lipin1-related rhabdomyoly... | 2021 | Cell Rep Med | Hamel Y. et al. | DOI: 10.1016/j.xcrm.2021.100370 |
| TLR 9 - HA | Compromised mitochondrial quality control triggers lipin1-related rhabdomyoly... | 2021 | Cell Rep Med | Hamel Y. et al. | DOI: 10.1016/j.xcrm.2021.100370 |
| Imiquimod (R837) | Compromised mitochondrial quality control triggers lipin1-related rhabdomyoly... | 2021 | Cell Rep Med | Hamel Y. et al. | DOI: 10.1016/j.xcrm.2021.100370 |
| ODN 2216 - TLR9 ligand | Compromised mitochondrial quality control triggers lipin1-related rhabdomyoly... | 2021 | Cell Rep Med | Hamel Y. et al. | DOI: 10.1016/j.xcrm.2021.100370 |
| Poly(I:C) HMW | Compromised mitochondrial quality control triggers lipin1-related rhabdomyoly... | 2021 | Cell Rep Med | Hamel Y. et al. | DOI: 10.1016/j.xcrm.2021.100370 |
| LPS-B5 (LPS from E. coli O55:B5) | Compromised mitochondrial quality control triggers lipin1-related rhabdomyoly... | 2021 | Cell Rep Med | Hamel Y. et al. | DOI: 10.1016/j.xcrm.2021.100370 |
| Pam3CSK4 | Development of an Optimized Culture System for Generating Mouse Alveolar Macr... | 2021 | J Immunol. | Luo M. et al. | DOI: 10.4049/jimmunol.2100185 |
| ODN 1668 - TLR9 ligand | Development of an Optimized Culture System for Generating Mouse Alveolar Macr... | 2021 | J Immunol. | Luo M. et al. | DOI: 10.4049/jimmunol.2100185 |
| Anti-HER2 (Trastuzumab biosimilar - IgG1 isotype) | Artificial Intelligence Based Framework to Quantify the Cardiomyocyte Structu... | 2021 | Cardiovasc Eng Technol. | Abdeltawab H. et al. | DOI: 10.1007/s13239-021-00571-6 |
| THP1-Dual™ Cells | Modification and enhanced anti-inflammatory activity by Bifidobacterial ferme... | 2021 | Int J Biol Macromol. | Li L.Q. et al. | DOI: 10.1016/j.ijbiomac.2021.08.084 |
| Flagellin FliC VacciGrade™ | Generation of equine enteroids and enteroid-derived 2D monolayers that are re... | 2021 | Vet Res. | Hellman S. | DOI: 10.1186/s13567-021-00976-0 |
| A549-Dual™ KO-RIG-I Cells | Ligase Pellino3 Regulates Macrophage Action and Survival in Response to VSV I... | 2021 | Oxid Med Cell Longev. | Reniewicz P. et al. | DOI: 10.1155/2021/6668463 |
| A549-Dual™ Cells | Ligase Pellino3 Regulates Macrophage Action and Survival in Response to VSV I... | 2021 | Oxid Med Cell Longev. | Reniewicz P. et al. | DOI: 10.1155/2021/6668463 |
| IFN-α/β Reporter B16 Cells | Ligase Pellino3 Regulates Macrophage Action and Survival in Response to VSV I... | 2021 | Oxid Med Cell Longev. | Reniewicz P. et al. | DOI: 10.1155/2021/6668463 |